asco gu 2023: moving immunotherapy into the first-line setting for bladder cancer
Published 1 year ago • 136 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
3:31
the use of immunotherapy as a first-line therapy for bladder cancer
-
19:52
bladder cancer conference highlights from asco gu 2023
-
0:58
unmet needs in regards to immunotherapy for bladder cancer
-
1:33
hot topics in bladder cancer from asco gu 2023
-
0:47
what to look forward to in urothelial cancer at asco gu 2023
-
5:40
highlights in bladder cancer from asco gu 2021
-
1:06
key trials in bladder cancer from asco gu 2022
-
1:10
the difficulties in treating bladder cancer with immunotherapy
-
2:15
asco gu 2023: highlights in prostate cancer
-
4:45
highlights in kidney and bladder cancer at asco gu 2021
-
9:24
key updates in bladder cancer from asco gu 2021
-
1:27
highlights in kidney and bladder cancer at asco 2023
-
2:02
asco gu 2023: hot topics in prostate cancer
-
0:59
genitourinary cancer updates at asco 2023
-
3:00
exclusive highlights in genitourinary cancer at asco 2023
-
8:00
asco gu 2023 bladder cancer poster walk
-
5:48
asco gu 2023: urothelial carcinoma, comment pd dr. med. richard cathomas, chur
-
2:12
the rationale behind the phase iii trial on neoadjuvant intravesical mmc treatment of bladder cancer